SCHEMBL12683307

SCHEMBL12683307

CNc1c(Br)cccc1NO

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.34
▸ CXCR2 P25025 1/20 0.33
▸ EGFR P00533 1/20 0.32
▸ HTT P42858 4/20 0.32
▸ RAB9A P51151 2/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ ANPEP P15144 1/20 0.31
▸ LRRK2 Q5S007 1/20 0.31
▸ PDK1 Q15118 1/20 0.31
▸ PDK2 Q15119 1/20 0.31
▸ PDK3 Q15120 1/20 0.31
▸ PDK4 Q16654 1/20 0.31
▸ CXCR1 P25024 1/20 0.31
▸ ALDH1A1 P00352 4/20 0.31
▸ MAPT P10636 2/20 0.31
▸ TAAR1 Q96RJ0 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27647088 0.85 MAPT (0.38) L3MBTL1CXCR2EGFRHTTRAB9A
SCHEMBL20892638 0.79 ALDH1A1 (0.39) LRRK2ALDH1A1TAAR1
SCHEMBL29924488 0.74 CXCR2 (0.39) L3MBTL1CXCR2EGFRRAB9ANPC1
SCHEMBL12367893 0.74 ALDH1A1 (0.37) L3MBTL1EGFRHTTRAB9AMEN1
SCHEMBL29150052 0.74 CXCR2 (0.39) L3MBTL1CXCR2EGFRRAB9ANPC1
SCHEMBL17671219 0.72 — —
SCHEMBL11426617 0.71 ALDH1A1 (0.50) L3MBTL1MEN1KMT2ALMNAALDH1A1
SCHEMBL26488162 0.71 F2R (0.41) L3MBTL1EGFRHTTMEN1KMT2A
SCHEMBL25682582 0.71 CXCL8 (0.30) L3MBTL1EGFRRAB9AMAPTTDP1
SCHEMBL29924481 0.70 TAAR1 (0.32) ALDH1A1TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023109892-A1 COMPOUND FOR INHIBITING OR DEGRADING BRD9, AND COMPOSITION AND PHARMACEUTICAL USE THEREOF 海思科医药集团股份有限公司 2023-06-22 — — WO disclosed
WO-2012107465-A1 HETEROCYCLIC COMPOUNDS AS PI3 KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2012-08-16 — — WO disclosed
Send feedback